25.03.2016, 06:56
LifeWatch AG: LifeWatch publishes Annual General Meeting Invitation
OREANDA-NEWS. LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services to the digital health market, announces that it has today published the invitation to its annual general meeting.
The board is recommending in the invitation that shareholders authorize an ordinary capital increase of up to 5,000,000 shares in order to combat the potential liquidity shortfall caused by the Highmark award as well as provide resources for future growth and expansion.
Furthermore, the board is also recommending three new board members, which together with the two standing for re-election would mean that the board would consist of five members in the future. Below you will find a short summary on the three board candidates:
Raymond W. Cohen, a citizen of the Unites States of America, a proven leader, board member, entrepreneur, team-builder and creator of shareholder value with more than 30 years of private and public company experience. Accredited public company director and currently CEO of Axonics Modulation Technologies, Irvine, CA, U.S.A.
Dr. Didier Hoch, M.D., a French citizen, a seasoned former senior executive with more than 25 years' experience in the European and Near Middle Eastern pharmaceutical industry. Currently Chairman of Biovision and CEO of Big Booster, an international accelerator for start-ups.
John Doulis, M.B., B.S., Grad Dip Health Inf., an Australian citizen, permanent US resident. A physician executive with post-graduate training in health informatics. Currently Chief Informatics and Information Officer, MedCare Investment Funds; President and Chief Executive Officer of Artemis Healthcare Group and Adjunct Professor of Management, Vanderbilt University Owen Graduate School of Management.
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solutions' company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. For additional information, please visit www.lifewatch.com.
The board is recommending in the invitation that shareholders authorize an ordinary capital increase of up to 5,000,000 shares in order to combat the potential liquidity shortfall caused by the Highmark award as well as provide resources for future growth and expansion.
Furthermore, the board is also recommending three new board members, which together with the two standing for re-election would mean that the board would consist of five members in the future. Below you will find a short summary on the three board candidates:
Raymond W. Cohen, a citizen of the Unites States of America, a proven leader, board member, entrepreneur, team-builder and creator of shareholder value with more than 30 years of private and public company experience. Accredited public company director and currently CEO of Axonics Modulation Technologies, Irvine, CA, U.S.A.
Dr. Didier Hoch, M.D., a French citizen, a seasoned former senior executive with more than 25 years' experience in the European and Near Middle Eastern pharmaceutical industry. Currently Chairman of Biovision and CEO of Big Booster, an international accelerator for start-ups.
John Doulis, M.B., B.S., Grad Dip Health Inf., an Australian citizen, permanent US resident. A physician executive with post-graduate training in health informatics. Currently Chief Informatics and Information Officer, MedCare Investment Funds; President and Chief Executive Officer of Artemis Healthcare Group and Adjunct Professor of Management, Vanderbilt University Owen Graduate School of Management.
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solutions' company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland and in Israel, and is the parent company of LifeWatch Services Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services and home sleep testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd., based in Israel, is a leading developer and manufacturer of telemedicine products. For additional information, please visit www.lifewatch.com.
Комментарии